RUNX2 and craniosynostosis: Furthermore, the aberrant upregulation of fibroblast growth factor receptors (FGFRs) is implicated in the pathophysiology of craniosynostosis through Runx2, having as clinical manifestations the premature fusion of sutures, the concomitant deformation of the skull, and facial hypoplasia.